LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression

HCC is one of the most common malignant tumors worldwide. Although traditional treatment methods have been improved in recent years, the survival rate of HCC patients has not been significantly improved. Immunotherapy has shown extremely high clinical value in a variety of tumors. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Rongshou, Liu, Weiwei, Yang, Qingping, Zhang, Jingling, Hou, Ping, Xiong, Jianghui, Wu, Linquan, Li, Enliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562488/
https://www.ncbi.nlm.nih.gov/pubmed/37813900
http://dx.doi.org/10.1038/s41598-023-42948-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562488/
https://www.ncbi.nlm.nih.gov/pubmed/37813900
http://dx.doi.org/10.1038/s41598-023-42948-8

Ejemplares similares